These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33928245)

  • 1. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.
    Mukherjee S; Perez KA; Lago LC; Klatt S; McLean CA; Birchall IE; Barnham KJ; Masters CL; Roberts BR
    Brain Commun; 2021; 3(2):fcab028. PubMed ID: 33928245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11C-PiB PET can underestimate brain amyloid-β burden when cotton wool plaques are numerous.
    Abrahamson EE; Kofler JK; Becker CR; Price JC; Newell KL; Ghetti B; Murrell JR; McLean CA; Lopez OL; Mathis CA; Klunk WE; Villemagne VL; Ikonomovic MD
    Brain; 2022 Jun; 145(6):2161-2176. PubMed ID: 34918018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.
    Roberts BR; Lind M; Wagen AZ; Rembach A; Frugier T; Li QX; Ryan TM; McLean CA; Doecke JD; Rowe CC; Villemagne VL; Masters CL
    Brain; 2017 May; 140(5):1486-1498. PubMed ID: 28383676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software.
    Mukherjee S; Fjeldsted JC; Masters CL; Roberts BR
    Anal Bioanal Chem; 2022 Jul; 414(18):5683-5693. PubMed ID: 35426495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aspartic acid-bond isomerization on in vitro properties of the amyloid beta-peptide as modeled with N-terminal decapeptide fragments.
    Szendrei GI; Prammer KV; Vasko M; Lee VM; Otvos L
    Int J Pept Protein Res; 1996 Apr; 47(4):289-96. PubMed ID: 8738655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.
    Shinohara M; Koga S; Konno T; Nix J; Shinohara M; Aoki N; Das P; Parisi JE; Petersen RC; Rosenberry TL; Dickson DW; Bu G
    Brain; 2017 Dec; 140(12):3301-3316. PubMed ID: 29161341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrullination of Amyloid-β Peptides in Alzheimer's Disease.
    Mukherjee S; Perez KA; Dubois C; Nisbet RM; Li QX; Varghese S; Jin L; Birchall I; Streltsov VA; Vella LJ; McLean C; Barham KJ; Roberts BR; Masters CL
    ACS Chem Neurosci; 2021 Oct; 12(19):3719-3732. PubMed ID: 34519476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
    Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of post-translational racemization and isomerization of N-terminal amyloid-β in Alzheimer's brain tissues by covalent chiral derivatized ultraperformance liquid chromatography tandem mass spectrometry.
    Inoue K; Hosaka D; Mochizuki N; Akatsu H; Tsutsumiuchi K; Hashizume Y; Matsukawa N; Yamamoto T; Toyo'oka T
    Anal Chem; 2014 Jan; 86(1):797-804. PubMed ID: 24283798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease.
    Shimizu T; Fukuda H; Murayama S; Izumiyama N; Shirasawa T
    J Neurosci Res; 2002 Nov; 70(3):451-61. PubMed ID: 12391606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.
    Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C
    Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
    Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
    Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a selective and sensitive analytical method to detect isomerized aspartic acid residues in crystallin using a combination of derivatization and liquid chromatography mass spectrometry.
    Mizuno H; Shindo T; Ito K; Sakane I; Miyazaki Y; Toyo'oka T; Todoroki K
    J Chromatogr A; 2020 Jul; 1623():461134. PubMed ID: 32345439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racemization: its biological significance on neuropathogenesis of Alzheimer's disease.
    Mori H; Ishii K; Tomiyama T; Furiya Y; Sahara N; Asano S; Endo N; Shirasawa T; Takio K
    Tohoku J Exp Med; 1994 Nov; 174(3):251-62. PubMed ID: 7761990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.